{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:58:56Z","timestamp":1780894736991,"version":"3.54.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is an acute leukemia characterized by aberrant proliferation of myeloid blasts in the bone marrow. Auer bodies are identifiable in the blasts of certain AML subtypes, but their \u201cfaggot-like\u201d aggregation is uncommon, associated with strong peroxidase positivity, and readily misidentified as abnormal promyelocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 79-year-old male was admitted for leukocytosis detected on physical examination. One month prior, he had marked leukocytosis (unspecified value) with predominant monocyte elevation. Admission complete blood count (CBC) confirmed leukocytosis and elevated monocyte percentage. Peripheral blood (PB) smear demonstrated 35% abnormal leukocytes, and bone marrow (BM) aspirate revealed these cells accounting for 40%. Morphologically, the cells had round nuclei and abundant cytoplasmic granules, with most of the cytoplasm filled with \u201cfaggot-like\u201d Auer bodies (strongly positive for peroxidase). Flow cytometry revealed blasts positive for CD117, CD33, and MPO, with minimal positivity for CD13. Further investigations (leukemia fusion gene detection, FISH, chromosome Analysis, next-generation sequencing, and whole-transcriptome sequencing) failed to detect any APL-specific fusion genes, and the patient was ultimately diagnosed with non-M3 subtype AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case is a special type of acute myeloid leukemia (AML) with morphological features highly resembling acute promyelocytic leukemia (APL) but without the associated fusion gene. Faggot-like Auer bodies, once considered a hallmark of APL, are not pathognomonic for APL, and diagnosis based solely on morphology is susceptible to misdiagnosis. This report aims to accumulate clinical experience, provide a reference for the diagnosis and management of similar cases, and reduce the incidence of misdiagnosis and missed diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1791126","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:32Z","timestamp":1780892612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The appearance of \u201cfaggot Auer rods\u201d in blasts of non-M3 acute myeloid leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Cui","family":"Zhang","sequence":"first","affiliation":[{"name":"Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.8227","article-title":"Acute promyelocytic leukemia: Current management and future perspectives","volume":"31","author":"Lo-Coco","year":"2013","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0049","article-title":"Acute promyelocytic leukemia: NCCN clinical practice guidelines in oncology (Version 2.2023)","volume":"21","author":"Tallman","year":"2023","journal-title":"J Natl Compr Cancer Network"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30010-X","article-title":"Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study","volume":"19","author":"DiNardo","year":"2018","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90112-c","article-title":"Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML","volume":"66","author":"Kakizuka","year":"1991","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80044-f","article-title":"The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells","volume":"74","author":"Grignani","year":"1993","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1708\/494.5814","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-269621","article-title":"Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710","volume":"116","author":"Powell","year":"2010","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000444514","article-title":"Molecular characteristics and clinical significance of 12 fusion genes in acute promyelocytic leukemia: a systematic review","volume":"136","author":"Yan","year":"2016","journal-title":"Acta Haematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-528596","article-title":"TBLR1 fuses to retinoid acid receptor \u03b1 in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-807370","article-title":"Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)\/PML-RARA","volume":"131","author":"Yao","year":"2018","journal-title":"Blood"},{"key":"B12","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2022"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-022-03430-4","article-title":"The 2022 international consensus classification of myeloid neoplasms and acute leukemia: A report of the international consensus classification (ICC) task force","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530150823","article-title":"Acute myeloid leukemia","volume":"387","author":"D\u00f6hner","year":"2022","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2022.2022-8-69","article-title":"Auer rod-like inclusions in a patient with multiple myeloma","volume":"39","author":"Bouanani","year":"2022","journal-title":"Balkan Med J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2021.06.018","article-title":"Lymphocytes with auer rod-like inclusions in chronic lymphocytic leukemia","volume":"44","author":"Rold\u00e1n Galiacho","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.exphem.2019.08.003","article-title":"Auer rod-like inclusions in the cytoplasm of B-cell lymphoma cells with bone marrow infiltration","volume":"77","author":"Gao","year":"2019","journal-title":"Exp Hematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmab051","article-title":"Variant acute promyelocytic leukemia presenting without auer rods highlights the need for correlation with cytogenetic data in leukemia diagnosis","volume":"53","author":"Courville","year":"2022","journal-title":"Lab Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7150\/ijcep.6679","article-title":"Clinicopathological features of acute promyelocytic leukemia: An experience in one institute emphasizing the morphological and immunophenotypic changes at the time of relapse","volume":"6","author":"Yoshii","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-748-TVOCEI","article-title":"The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: A flow cytometric analysis of 64 cases","volume":"131","author":"Dunphy","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10694","article-title":"The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes","volume":"91","author":"Albano","year":"2006","journal-title":"Haematologica"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.leu.2404412","article-title":"Flow cytometry analysis of acute promyelocytic leukemia: The power of 'surface hematology'","volume":"21","author":"Di Noto","year":"2007","journal-title":"Leukemia"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20814","article-title":"Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: A multi-center study in Shanghai, China","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12885-019-5602-8","article-title":"The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematic-review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1791126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:34Z","timestamp":1780892614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1791126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":24,"alternative-id":["10.3389\/fonc.2026.1791126"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1791126","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1791126"}}